By understanding these early systemic changes, her work is opening new doors for preventing melanoma spread before it takes hold. 😎
Join us at #MRS2026 to learn more
🗓 When: June 28 – July 1, 2026
📍 Where: Salt Lake City, Utah
👉 Register & Save: metastasis-research.org/membership-a...
🔬 Dr. Levy’s research provides a fascinating look at how external environmental cues, such as UVB ☀️ exposure, impact the internal progression of melanoma. Her lab is looking at how tumor-derived extracellular vesicles & malignant-immune cell communications drive tumor initiation & metastasis
🚨#MRS2026 early bird registration until April 30th. From sun exposure to cell signaling: Spotlight on Dr. Carmit Levy ☀️ We are thrilled to announce that Dr. Carmit Levy from Tel Aviv University #TelAvivUni will be a featured speaker at #MRS2026 in Salt Lake City!
🗓 Mark your calendars: June 28 – July 1, 2026
📍 Location: Salt Lake City, Utah
👉 Join the MRS community: metastasis-research.org/membership-a...
#MRS2026 #GelarehZadeh #NeuroOncology #BrainTumor #LiquidBiopsy #PrecisionMedicine #Metastasis #WomenInMedicine
By understanding how the tumor microenvironment drives progression in the central nervous system 🧠, her work is paving the way for more precise and effective treatments for brain metastasis and primary tumors alike.
🔬 A world-renowned neurosurgeon-scientist, Dr. Zadeh is a pioneer in the field of neuro-oncology. Her research explores the genomic and epigenomic landscape of brain tumors, with a focus on identifying non-invasive biomarkers like liquid biopsies. 🧪
Decoding the brain’s epigenome: Spotlight on Dr. Gelareh Zadeh @gelarehzadeh.bsky.social 🧠 We are honored to announce that Dr. Gelareh Zadeh (Mayo Clinic / University of Toronto) will be a featured speaker at our Biennial Congress #MRS2026.
👉 register: metastasis-research.org/2024/06/26/m...
🗓 When: June 28 – July 1, 2026
📍 Where: Salt Lake City, Utah
👉Register:
metastasis-research.org/2024/06/26/m...
#MRS2026 #MasanoriTachikawa #BloodBrainBarrier #DrugDelivery #Pharmacokinetics #Metastasis #TohokuUniversity #NeuroOncology
By decoding how drugs and endogenous substances move across these physiological gates, his work is laying the foundation for more effective delivery of therapeutics to the central nervous system.
A leading expert in molecular pharmacokinetics, Dr. Tachikawa’s research is essential for understanding how we can bypass the blood-brain barrier (BBB) to treat metastatic disease. His lab utilizes quantitative targeted proteomics to map the transport systems of the BBB and the blood-CSF barrier.
🚨Only 2 weeks left to take advantage of early bird registration discounts for #MRS2026! Early bird registration for members until April 30! We are proud to welcome Dr. Masanori Tachikawa (Tohoku University) to the #MRS2026 speaker lineup!
Join us at #MRS2026
🗓 Mark your calendars: June 28 – July 1, 2026
📍 Location: Salt Lake City, Utah
👉 Join the MRS community & save: metastasis-research.org/membership-a...
#UriBenDavid #Aneuploidy #PrecisionMedicine #Genomics #CancerBiology #Metastasis #ComputationalBiology
Aneuploidy—the presence of an abnormal number of chromosomes—is a defining hallmark of cancer, yet its role in metastasis remains a complex puzzle. The Ben-David lab explores the origins and cellular consequences of aneuploidy paving the way for the next generation of precision medicine.
Targeting the hallmark of aneuploidy with Dr. Uri Ben-David 🧬 The #MRS2026 lineup continues to impress! We are honored to welcome Dr. Uri Ben-David (Tel Aviv University) to the stage this June.
🗓 June 28 – July 1, 2026
📍 Salt Lake City, Utah
👉 registration: metastasis-research.org/2024/06/26/m...
Join us in Utah for #MRS2026 to hear more about Dr. Gomes' research. Stay tuned for more #speakerhighlights!
🗓 When: June 28 – July 1, 2026
📍 Where: Salt Lake City, Utah
👉 Early bird registration for members until April 30! Register here: metastasis-research.org/2024/06/26/m...
Dr. Gomes' lab investigates how age-driven metabolic changes reprogram the TME to promote metastasis. By uncovering how the aged body provides a fertile soil for metastatasis, her research offers a new insights for the development of therapies specifically for elderly patients lab.moffitt.org/gomes
⏳ The clock and the cancer: How does the aging process influence cancer spread? We are thrilled to host Ana Gomes, PhD from the Moffitt Cancer Center in our speaker countdown to #MRS2026! 🔬
👉 Early bird registration for members until April 30! Register here: metastasis-research.org/2024/06/26/m...
Join us in Utah for the #MRS2026 meeting to learn more about Dr. Shevde’s research and don't miss our early career sessions hosted by the MRS ECLC!
🗓 June 28 – July 1, 2026
📍 Salt Lake City, Utah
👉 Early bird registration for members until April 30! metastasis-research.org/2024/06/26/m...
🔬 Additionally, Dr. Shevde conceptualized and developed the Early Career Ambassadors of Metastasis Research (ECAM) program and the ECLC in the MRS to train and mentor the next generation of metastasis investigators!
🔬 Dr Shevde is a Professor in the Department of Pathology in the NCI designated UAB O'Neal Cancer Center. Her work aims to decipher signaling events that program tumor cells & their microenvironment to facilitate metastatic progression and treatment resistance.
👉 sites.uab.edu/lsamant/home/
We are excited to announce Dr. Lalita Shevde from the University of Alabama Birmingham in our speaker countdown to #MRS2026.
We look forward to hearing her insights at #MRS2026, this is a session you won’t want to miss!
🗓 June 28 – July 1, 2026
📍 Salt Lake City, Utah
👉 Early bird registration for members until April 30!
Become a member & save: metastasis-research.org/membership-a...
🔬 Recent work from Dr. Parker’s group aims to translate stromal biomarkers into tools for risk stratification and to develop immune‑based approaches that improve outcomes for patients with metastatic disease.
🔬 Dr. Belinda Parker is a Group Leader at the @petermaccc.bsky.social . Her lab investigates tumor–host crosstalk with a focus on stromal biomarkers that predict early breast cancer recurrence and on immunotherapeutic strategies for breast and prostate cancer.
👉 www.petermac.org/research/res...
We continue the #MRS2026 #speakerhighlight, introducing Dr. Belinda Parker from @petermaccc.bsky.social! 🌟 🧵👇
🗓 June 28 – July 1, 2026
📍 Salt Lake City, Utah
👉 Early bird registration for members until April 30! Register here: metastasis-research.org/2024/06/26/m...
We look forward to learning more about Leonie Young’s latest insights into resistance, metastasis, & translational opportunities in breast cancer.
Join us at #MRS2026 — you won’t want to miss it!
🗓 June 28 – July 1, 2026
📍 Salt Lake City, Utah
🌐 Registation 👉 metastasis-research.org/2024/06/26/m...
🔬 Recent work reveals how SRC‑regulated transcriptional programs & RNA‑modifying enzymes contribute to metastatic colonization & treatment failure. Her team aims to identify new predictive markers and therapeutic targets to improve patient outcomes. 👇
pubmed.ncbi.nlm.nih.gov/41092317/
🔬 Prof. Leonie Young is a leading investigator whose research uncovers the molecular networks driving therapy resistance & metastatic progression in #BreastCancer. Her lab focuses on SRC‑mediated resistance pathways & mechanisms that shape tumor adaptation in #BrainMetastases.
It is a great pleasure to introduce Prof. Leonie Young from @rcsi.bsky.social in our next #speakerhighlight 🌟 for #MRS2026 🧵👇
🗓 June 28 – July 1, 2026
📍 Salt Lake City, Utah
🚨Early bird & membership discount until April 30!
🌐 Registration 👉
metastasis-research.org/2024/06/26/m...
🔬 Prof. Leonie Young is a leading investigator whose research uncovers the molecular networks driving therapy resistance & metastatic progression in #BreastCancer. Her lab focuses on SRC‑mediated resistance pathways & mechanisms that shape tumor adaptation in #BrainMetastases.